Financial Ratios

VARDHAMAN LABORATORIES LTD.

NSE : NABSE : 524796ISIN CODE : INE503F01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.510 (0 %)
PREV CLOSE ( ) 0.51
OPEN PRICE ( ) 0.51
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2000
TODAY'S LOW / HIGH ( )0.51 0.51
52 WK LOW / HIGH ( ) 0.490.66
NSE
This Company is not listed in NSE
Select year
ParticularsMar2018Mar2017Mar2016Mar2015Mar2014
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.10-0.09-0.08-0.06-0.05
   CEPS(Rs)-0.10-0.09-0.08-0.06-0.05
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)4.854.945.035.115.17
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)
   EBIT Margin(%)
   Pre Tax Margin(%)
   PAT Margin (%)
   Cash Profit Margin (%)
Performance Ratios
   ROA(%)-1.96-1.79-1.49-1.23-1.02
   ROE(%)-1.98-1.81-1.50-1.23-1.02
   ROCE(%)-1.98-1.76-1.47-1.22-1.00
   Asset Turnover(x)0.000.000.000.000.00
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.000.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)
   Receivable days
   Inventory Days
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-6.80-7.66-15.36-22.920.00
   Price/Book(x)0.140.140.230.280.00
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)
   EV/Core EBITDA(x)3.825.461.66-2.32-181.24
   EV/EBIT(x)3.825.461.66-2.32-181.24
   EV/CE(x)-0.08-0.10-0.020.031.82
   M Cap / Sales
Growth Ratio
   Net Sales Growth(%)
   Core EBITDA Growth(%)-10.63-17.46-19.25-20.311.78
   EBIT Growth(%)-10.63-17.46-19.25-20.3144.29
   PAT Growth(%)-7.75-18.34-20.38-19.3377.19
   EPS Growth(%)-7.79-18.24-20.38-19.4377.20
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)70.12170.6390.71681.00407.21
   Quick Ratio(x)70.12170.6390.71681.00407.21
   Interest Cover(x)-1740.70-36.58-50.84-98.87-54.43
   Total Debt/Mcap(x)0.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.